某院2011~2015年病原菌分布及耐药趋势分析
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

泸州市科技局课题[2013S46(2/6)]


Analysis of hospital bacteria distribution and drug resistance in 2011~2015
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】〓目的〓了解临床病原菌分布及其对抗菌药物的耐药性,为临床合理用药提供参考。 方法〓对我院2011年1月~2015年12月分离病原菌的流行分布及其耐药性情况进行分析,依据2014CLSI标准判断结果,用WHONET 5.6软件进行数据分析。结果〓经培养共分离出病原菌8645株,其中革兰阴性菌(G-)6886株(797%),革兰阳性菌(G+)1759株(203%)。病原菌感染位居前10位的是大肠埃希菌、肺炎克雷伯菌、金黄色葡萄球菌、铜绿假单胞菌、流感嗜血杆菌、肺炎链球菌、鲍曼不动杆菌、阴沟肠杆菌、卡他莫拉菌和奇异变形杆菌。革兰阳性球菌中,金黄色葡萄球菌的MRSA检出率为174%;肠杆菌科中,大肠埃希菌和肺炎克雷伯菌产超广谱酶(ESBLs)率分别为445%和197%。对碳青霉烯类耐药的大肠埃希菌和肺炎克雷伯菌分别为04%和09%;对碳青霉烯类耐药的铜绿假单胞菌和鲍曼不动杆菌分别为186%和252%;未发现对万古霉素耐药的粪肠球菌和屎肠球菌。结论〓进行病原学检测, 了解病原菌分布及耐药性,对合理使用抗菌药物及减少耐药菌的产生具有重要临床意义。

    Abstract:

    【Abstract】〓Objective〓To analyze the distribution of clinical pathogenic bacteria and it's drug resistance and provide laboratory evidence for clinical treatment.Methods〓 Based on the technique of 2014CLSI,the WHONET 56 was used to analyze the data of the distribution and drug resistance of all clinical isolates from the hospital during this 5 years.Results〓A total of 8645 strains bacteria were isolated, including 6886(693%)Gramnegative bacteria and 1759(307%)Grampositive bacteria strains. The top 10 bacteria were E. coli, Klebsiella pneumonia, Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenza, Streptococcus pneumonia, Acinetobacter baumannii, Enterobacter cloacae, Moraxella catarrhalis, Proteus mirabilis. In Grampositive bacteria, Staphylococcus aureus (MRSA) detection rates were 174%. In Enterobacteriaceae, E. coli and klebsiella pneumonia bacteria (ESBLs) rate were 445% and 197% respectively. The rate of E. coli and klebsiella pneumonia with Carbapenemsresistant were 04% and 09% respectively, but 186% Pseudomonas aeruginosa and 252% Acinetobacter baumannii were found. There was no E faecium and E faecalis which was resistant to vancomycin.Conclusion〓〓It has great significance to investigate and analyze the pathogenic bacteria with their distribution and drug resistance for clinical treatment and reduction of drug resistant.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-11-10
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司